Bayer AG (BAYRY) Receives FDA Approval For Expanded MR Injector Application [Yahoo! Finance]
BAYER AG S/ADR (BAYRY)
NASDAQ:AMEX Investor Relations:
investor.bayer.com
Company Research
Source: Yahoo! Finance
has cleared its MEDRAD MRXperion MR injector system for expanded application. That means this contrast injector system can now be used across a broader range of MRI scanners, including those with magnetic fields up to 7 Tesla. Bayer AG (BAYRY) Receives FDA Approval For Expanded MR Injector Application Bayer's MEDRAD MRXperion is used in MRI diagnostic procedures for delivering contrast agents and saline. This system is part of Bayer's radiology segment where sales jumped 9% YoY to €2.2 billion in 2025. Bayer released its Q4 and full-year 2025 earnings report on March 4. The report showed revenue rose 1.1% to €45.6 billion. That company absorbed €1.74 billion in adverse currency effects in 2025. For 2026, Bayer is expecting revenue in the band of €43.7 billion to €45.7 billion on a currency-adjusted basis. The company is anticipating EBITDA before special items to be in the range of €9.1 billion to €9.6 billion. Regarding the 2026 outlook, Bayer CEO Bill Anderson said it reflec
Show less
Read more
Impact Snapshot
Event Time:
BAYRY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BAYRY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BAYRY alerts
High impacting BAYER AG S/ADR news events
Weekly update
A roundup of the hottest topics
BAYRY
News
- Bayer Crop Science Launches 2026 Opportunity Scholarship ProgramBusiness Wire
- Bayer Aktiengesellschaft (BAYRY) was upgraded by UBS Group AG from "neutral" to "buy".MarketBeat
- KERENDIA® (finerenone) Meets Primary Endpoint in Investigational Phase III FIND-CKD Study in Patients with Non-Diabetic Chronic Kidney DiseaseBusiness Wire
- Will RFK Jr.'s MAHA voters shun GOP in midterms over 'major mistake'? [USA TODAY]USA TODAY
- Bayrab (Bayer) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, & Forecasts, 2020-2025, 2025-2030F, 2035F [Yahoo! Finance]Yahoo! Finance